N@N

Irina Rivkind Koffler Maintained (TEVA) at Strong Buy with Increased Target to $29 on, Sep 17th, 2018

^{Published on 2024-10-26 08:47:26 - WOPRAI, Irina Rivkind Koffler}
 

Irina Rivkind Koffler of Mizuho, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Strong Buy with Increased Target from $28 to $29 on, Sep 17th, 2018.

Irina has made no other calls on TEVA in the last 4 months.

There are 5 other peers that have a rating on TEVA. Out of the 5 peers that are also analyzing TEVA, 4 agree with Irina's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Douglas Tsao of "Barclays" Maintained at Hold with Increased Target to $23 on, Monday, August 6th, 2018
• David Risinger of "Morgan Stanley" Maintained at Hold with Increased Target to $20 on, Friday, August 3rd, 2018
• Louise Chen of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $25 on, Monday, July 16th, 2018
• Jacob Hughes of "Wells Fargo" Upgraded from Sell to Hold on, Monday, June 18th, 2018

This is the rating of the analyst that currently disagrees with Irina

---

• Liav Abraham of "Citigroup" Maintained at Strong Buy with Increased Target to $25 on, Thursday, May 31st, 2018

Contributing Sources

---